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Available online 1 June 2016First study on the complete genome characterization of Dengue-3 virus is reported from den-
gue endemic state Rajasthan, India. The genome of 10,672 base pairs was studied with refer-
ence to global and the regional genomes of Dengue-3 virus. 388 variations were observed in
the nucleotide sequences with reference to the NCBI genome, including 34 variations in the
amino acids. Of these 34 AA variations, 4 variations showed AA substitution in Envelope pro-
teins and 1 in Anchored capsid region. The remaining 29 variations were observed in amino
acids constituting non structural (NS) proteins. The reported mutations, especially those lead-
ing to amino acid variations in non-structural proteins of virus may inﬂuence the clinical pro-
ﬁle of patients and accuracy of ongoing diagnostic tests. Reported amino acid variations in virus
envelope may inﬂuence the immune response of patients. Phylogenetic studies showed simi-
larity of reported genome with genomes from India, Pakistan and China.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Dengue Fever (DF) with Dengue Hemorrhagic Fever (DHF) is spreading fast world wide (390 million cases annually) (Bhatt et
al., 2013) including India as one of the endemic countries (more than 90,000 cases in 2015) (www.nvbdcp.gov.in). In India, al-
though the disease burden due to dengue is increasing yet there have been very few studies on its genomic constitution and
no studies from the disease endemic state Rajasthan. So far, some studies on the partial genomic segments (Kukreti et al.,
2009, 2008; Domingo et al., 2006) and some studies on complete genomes of Dengue-1 and Dengue-3 viruses have been pub-
lished (Patil et al., 2011; Dayaraj et al., 2011; Anoop et al., 2012; Sharma et al., 2011). Dengue is single stranded positive sense
RNA genome and is one of the fastest mutating arbo-viruses (Drake, 1993; Holmes and Burch, 2000). A signiﬁcant variation in
its nucleotide sequence which leads to amino acid alterations may facilitate the synthesis of modiﬁed viral proteins in the host
cell interfering the normal immune response of the dengue patient. Owing to increasing disease burden due to dengue, periodic
genomic surveillance of circulating dengue viruses is a necessity.
The state of Rajasthan, India is one of the worst affected states from dengue. The disease was ﬁrst reported from the state in
the year 1969 (Padbidri et al., 1973) and Dengue-3 was reported as the causative virus type (Padbidri et al., 1973). So far, no part
or complete genome sequence of any of the dengue strains has been reported from Rajasthan, India. We have studied wholeolecular Biology, Desert Medicine Research Centre, Pali Road, Jodhpur 342 005, India.
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33A. Angel et al. / Virology Reports 6 (2016) 32–40genome of Dengue-3 virus from a DHF patient, analysed its phylogeny and have studied nucleotide sequence variations and cor-
responding amino acid variations. Present paper reports the details.
2. Results
2.1. Comparison of sequence variations between cell line passaged and un-passaged samples
The serum sample from the DHF patient was subjected to nucleotide sequence determination directly as well after passaging
in C6/36 cell lines of Aedes albopictus mosquitoes. In both the cases (direct as well as cell passaged sample) the same observations
of nucleotide sequences and the associated amino acid variations were observed.
2.2. Whole genome characterization of Dengue-3 virus
Complete genome of Dengue-3 virus was sequenced. In total 10, 674 base pairs (bp) in un-passaged sample and 10,672 bp in
passaged sample were analysed for their nucleotide sequence. The polyprotein gene range in case of unpassaged genome was
from 88 to 10,260 while that of passaged genome was from 86 to 10,258. The entire assembled sequence has been deposited
in the Gen Bank (unpassaged: Accession no.: KU216209; passaged: Accession no.: KU216208). The pair-wise nucleotide alignment
using BLAST showed that in ﬁrst 5 best matches, observed genome resembled the complete genome sequences of India, Pakistan,
China and Sri Lanka (Table 1). The observed sequence which is ﬁrst complete genome of Dengue-3 virus from Rajasthan, India
showed 98–99% identity with reported Indian genomes. The phylogenetic analysis of the genome is shown in Fig. 1.
2.3. Variations in nucleotide sequence of observed genome with reference to global and regional genomes
The whole genomes of the DENV-3 virus (unpassaged: Accession no.: KU216209; passaged: Accession no.: KU216208) were
subjected to mutation analysis. These genomes were compared taking two reference whole genomes sequences into consider-
ation: one with NCBI reference genome (Global genome, Accession no.: NC_ 001475.2) and another with genome of nearest phy-
logeny (Regional genome, Accession no.: JQ922556.1). The mutations in the nucleotide sequences were of two types; Substitution
and Insertion type. As many as 388 variations were observed in the reported genome sequence when compared with the NCBI
reference genome (global genome) and 109 variations were observed when compared with the regional genome (genome of
nearest phylogeny) (Table 2).
It was observed that when compared with the global genome (NC_001475.2), the observed Rajasthan genome showed one
insertion in the 5′UTR region (75th position; 75–76insT) and one insertion in the 3′UTR region (10436th position; 10,436–
10437insA), both showing non-coding effects (Table 3). The rest of 386 mutations were of substitution type, belonged to the cod-
ing region. Similarly, when the observed genome was compared with genome of nearest phylogeny (JQ922556.1), it showed one
insertion in the 5′UTR region (54th position; 54–55insT) and one in the 3′UTR region (10415th position; 10,415–10416insA). Rest
of 107 mutations observed were of substitution type (Table 4). It was also observed that when observed genome was compared
with global genome (NC_001475.2), mutations were observed in membrane glycoprotein precursor M whereas when compared
to genome of nearest phylogeny (JQ922556.1) this mutation was not observed.Table 1
Alignments of reported genome of Rajasthan, India with other published genomes of nearby phylogeny.
S.No Gene Bank data Max score Total score Query cover E value Identity Accession no.
1 Dengue virus 3 isolate DENV-3/IND/58760/2005, complete genome 18,714 18,802 99% 0.0 99% JQ922556.1
2 Dengue virus 3 isolate D3/Pakistan/55505/2007, complete genome 18,628 18,715 99% 0.0 99% KF041255.1
3 Dengue virus 3 strain GWL-25, complete genome 18,626 18,713 100% 0.0 99% AY770511.2
4 Dengue virus 3 isolate ND143 from India, complete genome 18,608 18,695 100% 0.0 99% FJ644564.1
5 Dengue virus 3 D3/Pakistan/43298/2006, complete genome 18,583 18,760 99% 0.0 99% KF041259.1
6 Dengue virus 3 isolate D3/Pakistan/52440/2006, complete genome 18,557 18,665 99% 0.0 99% KF014257.1
7 Dengue virus 3isolate D3/Pakistan/55709/2006, complete genome 18,557 18,665 99% 0.0 99% KF041256.1
8 Dengue virus 3 isolate DEL-72, complete genome 18,539 18,627 100% 0.0 99% GQ466079.1
9 Dengue virus 3 isolate D3/45251/2009, complete genome 18,518 18,605 99% 0.0 99% KF041258.1
10 Dengue virus 3 isolate D3/Pakistan/56/2008, complete genome 18,514 18,602 99% 0.0 99% KF041254.1
11 Dengue virus 3 isolate ZJYW2009, complete genome 18,500 18,587 100% 0.0 98% JF504679.1
12 Dengue virus 3 strain GZ2D3, complete genome 18,476 18,564 100% 0.0 98% JN662391.1
13 Dengue virus 3 isolate GZ1D3, complete genome 18,464 18,547 100% 0.0 98% GU353649.1
14 Dengue virus 3 isolate 13GDZDVS30D, complete genome 18,417 18,504 99% 0.0 98% KF954948.1
15 Dengue virus 3 isolate 13GDZDV30E, complete genome 18,411 18,499 99% 0.0 98% KF954949.1
16 Dengue virus 3 isolate DENV-3/IND/59826/2005, complete genome 18,406 18,493 99% 0.0 98% JQ922557.1
17 Dengue virus 3 isolate 13GDZSDV30A, complete genome 18,402 18,490 99% 0.0 98% KF954945.1
18 Dengue virus 3 isolate 13GDZDV30B, complete genome 18,399 18,486 99% 0.0 98% KF954946.1
19 Dengue virus 3 13GDZDV30C, complete genome 18,397 18,484 99% 0.0 98% KF954947.1
20 Dengue virus 3 isolate DENV-3/MZ/BID-V2418/1985, complete genome 18,110 18,198 99% 0.0 98% FJ882575.1
Fig. 1. Phylogenetic analysis of whole genome. (Fig shows a sub tree depicting location of Rajasthan genome in proximity to genomes from other parts of India followed by Pakistan and China.)
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Table 2
Comparative analysis of the observed genome with global and regional genomes.
Strain
Variations observed at nucleotide level Variation observed at amino acid level
With Global genome
NC_001475.2
With Regional genome
JQ922556.1
With Global genome
NC_001475.2
With Regional genome
JQ922556.1
DENV-3 isolate/Rajasthan, India (Accession
no.: KU216208)
388 109 34 25
DENV-3 Rajasthan, India (Accession no.:
KU216209)
388 109 34 25
35A. Angel et al. / Virology Reports 6 (2016) 32–402.4. Nucleotide sequence variations leading to amino acid alterations
Of the 388 variations observed in the nucleotide sequence of reported genome with reference to global genome, 34 variations
led to amino acid (AA) variations. Of these 34 AA variations, all of which were of substitute type, 4 variations showed AATable 3
Comparison of reported genome of Rajasthan, India with global genome referred by NCBI (NC_001475.2).
Dengue virus
genome
Total
mutations
observed Positions of observed mutations
Number and type of
nucleotide positions in
which mutation were
observed
Number and effect of
mutation observed
Substitution Insertion
Non
coding Silent
Mis
sense
5′UTR 2 65, 75 1 1 2 – –
Anchored capsid
protein C
9 109, 203, 235, 250, 256, 265, 289, 295, 383 9 – – 8 1
Membrane
glycoprotein
precursor M
10 496, 529, 556, 796, 856, 874, 878, 901, 905, 908 10 – – 10 –
Envelope protein
E
52 952, 976, 979, 995, 1009, 1030, 1099, 1174, 1217, 1234, 1253, 1264, 1306,
1402, 1423, 1438, 1447, 1499, 1555, 1567, 1589, 1618, 1636, 1654, 1729,
1765, 1780, 1879, 1900, 1936, 1939, 1969, 1996, 2023, 2026, 2056, 2083,
2104, 2110, 2113, 2119, 2125, 2128, 2145, 2146, 2149, 2248, 2260, 2329,
2341, 2344, 2383
52 – – 47 5
NS1 41 2429, 2434, 2440, 2452, 2464, 2482, 2506, 2521, 2524, 2542, 2548, 2557,
2560, 2566, 2578, 2611, 2662, 2689, 2693, 2713, 2794, 2839, 2935, 2945,
2947, 2974, 3073, 3106, 3111, 3112, 3115, 3142, 3166, 3169, 3250, 3282,
3313, 3328, 3370, 3373, 3400
41 – – 34 7
NS2A 30 3484, 3536, 3583, 3598, 3649, 3691, 3698, 3728, 3754, 3776, 3787, 3790,
3791, 3796, 3787, 3790, 3791, 3796, 3815, 3848, 3853, 3875, 3904, 3917,
3937, 3946, 3976, 3997, 4021, 4039, 4045, 4072, 4081, 4087
30 – – 27 3
NS2B 17 4198, 4270, 4279, 4291, 4292, 4324, 4354, 4402, 4405, 4406, 4420, 4423,
4447, 4450, 4478, 4489, 4501
17 – – 16 1
NS3 74 4519, 4523, 4579, 4591, 4604, 4636, 4726, 4750, 4766, 4789, 4819, 4848,
4858, 4861, 4870, 4915, 4921, 4936, 4960, 4978, 4990, 4996, 5041, 5059,
5077, 5080, 5134, 5140, 5170, 5171, 5251, 5272, 5320, 5347, 5350, 5404,
5452, 5455, 5461, 5467, 5578, 5581, 5584, 5605, 5611, 5647, 5659, 5689,
5713, 5803, 5816, 5848, 5920, 5996, 6004, 6016, 6025, 6028, 6082, 6094,
6100, 6118, 6158, 6160, 6178, 6187, 6214, 6223, 6241, 6250, 6259, 6289,
6328, 6331
74 – – 69 5
NS4A 17 6373, 6418, 6433, 6466, 6476, 6481, 6490, 6550, 6559, 6560, 6634, 6637,
6653, 6664, 6668, 6673, 6727
17 – – 15 2
Protein 2k 5 6784, 6796, 6808, 6810, 6817 5 – – 4 1
NS4B 30 6836, 6844, 6856, 6868, 6895, 6931, 7093, 7106, 7144, 7165, 7180, 7193,
7198, 7210, 7222, 7258, 7273, 7289, 7299, 7318, 7333, 7357, 7363, 7367,
7400, 7406, 7450, 7456, 7462, 7528
30 – – 27 3
NS5 97 7576, 7615, 7621, 7624, 7654, 7711, 7732, 7733, 7741, 7765, 7778, 7802,
7870, 7906, 7913, 7915, 7948, 7969, 7987, 8014, 8038, 8057, 8080, 8107,
8126, 8128, 8164, 8233, 8266, 8269, 8276, 8311, 8326, 8356, 8416, 8479,
8485, 8497, 8542, 8548, 8650, 8659, 8679, 8737, 8758, 8770, 8891, 8893,
8899, 8911, 8917, 8941, 9037, 9103, 9222, 9223, 9249, 9262, 9268, 9301,
9334, 9337, 9358, 9370, 9371, 9385, 9391, 9397, 9424, 9449, 9480, 9484,
9562, 9592, 9605, 9670, 9676, 9712, 9778, 9805, 9817, 9824, 9884, 9889,
9895, 9928, 9979, 10,018, 10,024, 10,060, 10,078, 10,084, 10,105, 10,201,
10,204, 10,237, 10,240
97 – – 84 13
3′UTR 4 10,280, 10,436, 10,558, 10,596 3 1 4 – –
388 386 2 6 341 41
Table 4
Comparison of reported genome of Rajasthan, India with the regional (nearest phylogenetic) genome (JQ92556.1).
Dengue virus
genome
Total
mutations
observed Positions of observed mutations
Number and type of
nucleotide positions in
which mutation were
observed
Number and effect of
mutation observed
Substitution Insertion
Non
coding Silent
Mis
sense
5′UTR 1 54 – 1 1 – –
Anchored capsid
protein C
2 88,330 2 – – 1 1
Membrane
glycoprotein
precursor M
0 – – – – – –
Envelope protein
E
22 931, 955, 974, 1070, 1078, 1153, 1196, 1232, 1426, 2083, 2089, 2104,
2107, 2120, 2169, 2182, 2248, 2294, 2308, 2320, 2323, 2347
22 – – 18 4
NS1 12 2408, 2413, 2536, 2545, 2590, 2641, 2773, 2808, 2818, 2948, 2953, 2992 12 – – 9 3
NS2A 4 3577, 3766, 3848, 3934 4 – – 3 1
NS2B 9 4232, 4233, 4252, 4255, 4258, 4265, 4333, 4385, 4457 9 – – 6 3
NS3 20 4751, 4768, 4787, 4894, 4957, 5038, 5134, 5230, 5233, 5300, 5563, 5712,
5788, 5790, 5813, 5983, 6137, 6196, 6261, 6337
20 – – 12 8
NS4A 5 6352, 6460, 6529, 6643, 6652 5 – – 5 –
Protein 2 k 2 6775, 6787 2 – – 2 –
NS4B 2 6842, 6910 2 – – 1 1
NS5 27 7600, 7603, 7691, 7692, 7849, 7892, 7993, 8036, 8305, 8335, 8395, 8490,
8575, 8737, 8755, 8870, 8909, 8910, 9151, 9202, 9241, 9280, 9370, 9691,
9757, 9908, 10,183
27 – – 20 7
3′UTR 3 10,248, 10,415, 10,537 2 1 3 – –
109 107 2 4 77 28
Table 5
Details of amino acid variations in the observed genome with reference to global genome.
S.No. Poly protein amino acid (AA) change Position Type Nucleotide (NT) change
1 Q97K 97 Sub 383c N A ROI: Anchored capsid protein C
2 V301I 301 Sub 995g N A ROI: Envelope protein E
3 T375A 375 Sub 1217a N G ROI: Envelope Protein E
4 A499T 499 Sub 1589 g N A ROI: Envelope protein E
5 E684A 684 Sub 2145a N C ROI: Envelope protein E; 2146a N C ROI: Envelope protein E
6 I779V 779 Sub 2429a N G ROI: NS1 protein
7 L867I 867 Sub 2693c N A ROI: NS1 protein
8 L951 M 951 Sub 2945c N A NS1 protein; 2947a N G ROI: NS1 protein
9 T1006S 1006 Sub 3111c N G ROI: NS1 protein; 3112t N C ROI: NS1 protein
10 S1063N 1063 Sub 3282g N A ROI: NS1 protein
11 L1148M 1148 Sub 3536 t N A ROI: NS2A protein
12 V1252I 1252 Sub 3848g N A ROI: NS2A protein
13 V1275I 1275 Sub 3917g N A ROI: NS2A protein
14 P1400A 1400 Sub 4292c N G ROI: NS2B
15 F1504L 1504 Sub 4604t N C ROI: NS3
16 T1585M 1585 Sub 4848c N T ROI: NS3
17 D1865E 1865 Sub 5689c N A ROI: NS3
18 H2022Y 2022 Sub 6158c N T ROI: NS3; 6160t N C ROI: NS3
19 D2128H 2128 Sub 6476g N C ROI: NS4A
20 V2192I 2192 Sub 6668g N A ROI: NS4A
21 T2239I 2239 Sub 6810c N T ROI: Protein 2k
22 M2393I 2393 Sub 7273g N A ROI: NS4B
23 S2399P 2399 Sub 7289t N C ROI: NS4B
24 F2402Y 2402 Sub 7299t N A ROI: NS4B
25 V2562I 2562 Sub 7778g N A ROI: NS5
26 S2607A 2607 Sub 7913t N G ROI: NS5; 7915t N A ROI: NS5
27 T2678A 2678 Sub 8126a N G ROI: NS5; 8128t N C ROI: NS5
28 A2862 V 2862 Sub 8679c N T ROI: NS5
29 I3043T 3043 Sub 9222t N C ROI: NS5; 9223a N T ROI: NS5
30 Q3052L 3052 Sub 9249a N T ROI: NS5
31 L3093V 3093 Sub 9371c N G ROI: NS5
32 T3119S 3119 Sub 9449a N T ROI: NS5
33 L3129P 3129 Sub 9480t N C ROI: NS5
34 E3310D 3310 Sub 10024a N C ROI: NS5
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proteins of Dengue-3 virus (Table 5).
When the observed genome of Rajasthan, India (Accession no.: KU216208) was compared with the genome of nearest phylog-
eny, it showed 5 AA variation in the genes comprising the structural protein region (1 in Anchored capsid C and 4 in Envelope
protein region) while remaining 20 variations were observed in the viral gene region coding non structural proteins.(Table 6).
The NS4A region did not show any AA variation.3. Discussion
Dengue is emerging as a public health problem in India with more than 90,000 cases reported ofﬁcially till November, 2015
(www.nvbdcp.gov.in). Pathogenesis of severe forms of dengue viz.; DHF and DSS is poorly understood and one of the reasons
for this could be the lack of sufﬁcient number of studies on genomic variations of circulating dengue viruses (Holmes and
Burch, 2000). Whole genome study has been emphasized upon as the basic need to understand mutation spectra of dengue vi-
ruses (Chao et al., 2005). However, except few studies from India (Domingo et al., 2006; Patil et al., 2011; Dayaraj et al., 2011;
Anoop et al., 2012; Sharma et al., 2011) very little knowledge is available on the mutation spectra of dengue in the country.
Present paper reports ﬁrst study of the complete genome of Dengue-3 virus from Rajasthan, India. The analysis showed large
number of variations in the nucleotide sequence with many variations leading to amino acid alterations in the viral proteins. In
present study we not only report 388 nucleotide variations and 34 AA variations by comparing our genome with global genome
but also report 109 nucleotide variations and 25 AA variations with reference to even regional genome (genome of nearest phy-
logeny) from Pune, Maharashtra, India. Same pattern of mutations observed in directly processed as well as cell passaged serum
strengthens the fact that observed mutations are established variations in reported genome and that these are not by chance. The
variations in nucleotide sequences especially those leading to AA variations in envelope and non structural proteins as reported in
present paper may help understand pathogenesis of severe dengue better in this part of world. While AA variations in the enve-
lope protein, as reported in present paper, may alter immunological response in terms of IgM antibody generation, the variations
in non structural proteins (NS) may inﬂuence NS1 diagnostic test which is in vast use for diagnosis of dengue in India. In the only
one study published so far on whole genome of Dengue-3 virus from India, no signiﬁcant mutations were reported (Holmes and
Burch, 2000), but our study reports signiﬁcant mutations. Few studies outside India have reported amino acid variations in the
structural and non structural proteins of dengue leading to its severe clinical stage, DHF (Leitmeyer et al., 1999), whereas other
studies have emphasized on role of non structural gene NS 2A associated with severe dengue (Bennett et al., 2003). The possible
association of the dengue virus 1 strain with the replicative advantage of the virus has also been reported by other workers (Shin
et al., 2013).
Phylogenetic analysis of the observed genome shows best matching with the complete genome of India, Pakistan, China and
Sri Lanka. The state of Rajasthan, India forms north-western border of country with Pakistan and dengue genome from India re-
sembling complete genome of neighbouring countries highlights signiﬁcant cross boarder disease ecology.Table 6
Details of amino acid variations in the observed genome with reference to the regional genome (nearest phylogeny).
S.No. Poly protein amino acid (AA) change Position Type Nucleotide (NT) change
1 R86K 86 Sub 330g N A ROI: Anchored capsid protein C
2 V301I 301 Sub 974g N A ROI: Envelope protein E
3 T375 A 375 Sub 1196a N G ROI: Envelope protein E
4 P683T 683 Sub 2120c N A ROI: Envelope protein E
5 V699D 699 Sub 2169t N A ROI: Envelope protein E
6 I779V 779 Sub 2408a N G ROI: NS1
7 S912N 912 Sub 2808g N A ROI: NS1
8 P959A 959 Sub 2948c N G ROI: NS1
9 F1259L 1259 Sub 3848t N C: ROI: NS2A
10 G1387I 1387 Sub 4232g N A ROI: NS2B; 4233g N T ROI: NS2B
11 Q1398K 1398 Sub 4265c N A ROI: NS2B
12 P1560A 1560 Sub 4751c N G ROI: NS3
13 T1572A 1572 Sub 4787a N G ROI: NS3
14 N1687K 1687 Sub 5134c N G ROI: NS3
15 G1880V 1880 Sub 5712g N T ROI: NS3
16 G1906V 1906 Sub 5790g N T ROI: NS3
17 G1914R 1914 Sub 5813g N C ROI: NS3
18 H2022Y 2022 Sub 6137c N T ROI: NS3
19 I2063K 2063 Sub 6261t N A ROI: NS3
20 V2257M 2257 Sub 6842g N A ROI: NS4B
21 L2540T 2540 Sub 7691c N A ROI: NS5; 7692t N C ROI: NS5
22 S2607A 2607 Sub 7892t N G ROI: NS5
23 G2806A 2806 Sub 8490g N C ROI: NS5
24 G2946K 2946 Sub 8909g N A ROI: NS5; 8910g N A ROI: NS5
25 T3279P 3279 Sub 9908a N C ROI: NS5
38 A. Angel et al. / Virology Reports 6 (2016) 32–40For the fast replicating and mutating human pathogens like dengue viruses, more studies of regional genomic variations espe-
cially those leading to variations in amino acids, need to be undertaken to understand and explain the clinical mysteries and/or
basis of severe forms of dengue in the region.
4. Methods
4.1. Details of the sample collection
Host laboratory is one of the designated laboratories in the network of Sentinel Centres for diagnosis of Dengue &
Chikungunya under auspices of National Vector Borne Disease Control Programme (NVBDCP), Ministry of Health & Family Wel-
fare, Government of India, New Delhi. Serum samples from suspected cases of dengue were collected by the treating physicians
as part of routine surveillance of disease and the samples stored in the treating hospital were referred to our laboratory for
conducting Mac-ELISA test. The samples were referred to our laboratory with name, age, sex and address of patient. One of au-
thors (VJ) obtained informed consent from the patient whose sample was used in present study.
Serum sample of a 23 years old male, from Balotra, Rajasthan, India, positive for NS1 antigen and IgM antibody (negative for
IgG antibody) was selected for the whole genome sequencing.
4.2. Cell line inoculation and detection of virus infectivity
C6/36 cell lines were commercially procured from National Centre for Cell Sciences (NCCS), Department of Biotechnology, Gov-
ernment of India, Pune, India and was inoculated with 200 μl of the patient's serum. After 24 h of inoculation, the cells were
tapped off and stored at −80 °C till further use. 5 μl of this cell suspension was taken for Indirect Fluorescence Antibody Test
(IFA Test) (Kuberski and Rosen, 1977) for conﬁrming virus presence.
4.3. Type speciﬁc identiﬁcation of DENV type present
Viral RNA was extracted using the QIAmp Viral RNA Extraction Kit (m/s Qiagen, CA) according to the manufacturer's protocol.
Instead of the recommended 140 μl sample in the ﬁrst step of extraction process, the positive DEN-V C6/36 cell suspension was
taken thrice i.e. in three vials of 140 μl each. 560 μl of lysis buffer was added to each eppendorf and centrifuged. 560 μl of 100%
ethanol was added to this solution and centrifuged brieﬂy. During the transfer of this lysed viral solution to the spin column, en-
tire volume of solution was carefully transferred to one spin column with 630 μl being centrifuged in one round (6 times in total).
This inclusion in protocol was made to ensure a good quantity of viral RNA at the elution level. Once the whole content was cen-
trifuged, the washing steps followed as mentioned in the protocol and ﬁnally viral RNA was eluted in 60 μl of Elution buffer (la-
belled as ‘passaged serum sample’). Same procedure was used to extract viral RNA from “unpassaged” sample.
For identiﬁcation of the speciﬁc DENV type present in the samples (both passaged and unpassaged samples), RT-PCR was per-
formed using the type speciﬁc primers as suggested by Lanciotti et al. (Lanciotti et al., 1992), 5 μl of the eluted RNA was reacted
with each primer type. The Superscript III One Step RT-PCR kit with Platinum Taq Polymerase (m/s Invitrogen, USA) was used
with the temperature conditions as mentioned in the protocol sheet. After the RT-PCR run, the ampliﬁed product was run in
2% Agarose gel.
4.4. Primer design
Owing to the similarities in different DENV genotypes (Holmes and Twiddy, 2003) and possibility of spatio-temporal diversity
in the circulating dengue genomes, designing of region speciﬁc primers appeared to be necessary. Indigenous primers were thus
designed keeping in view the speciﬁcity, sensitivity, amplicon size, properties of primer annealing, primer-dimer possibility, G-C
lock at 3′ end and the Melting temperature (Tm) of primers .
To address the spatio-temporal genomic diversity, the NCBI virus variation database (Resch et al., 2009) was searched. Com-
plete genomes of Dengue virus 3 serotype reported during the period of 1st January 2000 to 31st July 2015 from the countries of
Indian subcontinent viz.; India, Pakistan, Nepal, Myanmar and Bangladesh were subjected to local pair wise Multiple Sequence
Alignment using multithreaded program MAFFT (ver. 7.221) (Katoh and Standley, 2013; Altschul et al., 1990) to obtain conserved
genomic stretches of more than 15 bases. Using these short conserved sequences further bioinformatics analysis was carried out.
The resulting primer sets thus obtained were highly speciﬁc and sensitive at serotype level. Seventeen sets of primers were con-
structed which had ampliﬁed the whole DENV-3 genome as 17 overlapping fragments. These primers were got synthesized com-
mercially from M/S Euroﬁns, Bangalore, India. Working solution of 10 pmol concentration was prepared for the RT-PCR assay.
4.5. Reverse transcriptase-polymerase chain reaction (RT-PCR) and gene sequencing using the whole genome primers
RT-PCR was performed using the 17 designed primer sets and the Superscript III One step RT-PCR kit (M/s Invitrogen, USA)
according to the protocol sheet provided. This was performed using viral RNA of both passaged and unpassaged samples. After
ampliﬁcation, 5 μl of amplicons was run in 2% Agarose gel and bands were obtained for each of the 17 sets in both the sample
Fig. 2. Agarose gel assay displaying bands of the DENV-3 whole genome ampliﬁed with 17 set of distinct primers. (Amplicons generated using primers: L1: Frag-
ment 1, L2: Fragment 7, L3: Fragment 13, L4: Fragment 17, L5: Fragment 2, L6: Fragment 3, L7: Fragment 4, L8: Fragment 5, L9: Fragment 6, L10: Fragment 8, L11:
Fragment 9, L12: Fragment 10, L13: Fragment 11, L14: Fragment 12, L15: Fragment 14, L16: Fragment 15, L17: Fragment 16, L18: DNA marker showing two bright
bands of 1000 bp and 500 bp).
39A. Angel et al. / Virology Reports 6 (2016) 32–40types. The expected MW for each ampliﬁed product was approximately 800–1000 bp while those ampliﬁed with primer set 1st
and 17th, the MW was approximately 450–550 bp (Fig. 2).
Each of these 17 products were puriﬁed using the PCR puriﬁcation kit (M/s Qiagen, CA) and then were subjected to sequenc-
ing using the Big Dye Terminator v3.1 ready reaction kit (m/s ABI, USA). Subsequently, any unincorporated dNTP's were removed
using the Dye Ex 2.0 Spin kit (m/s Qiagen, CA). The puriﬁed products were then sequenced using the 16 capillary Genetic Ana-
lyzer (M/s ABI, USA).
4.6. Genome sequence and phylogenetic analysis
For Contig assembly to obtain the whole DENV-3 genome and its further analysis for identifying the variations in nucleotides
and amino acid, the SeqScape v2.6 (M/s ABI, USA) software was used. Reference based assembly was performed using NCBI ref-
erence genome for DENV-3 (NC_001475.2). Comparative genome analysis was also performed with nearest genome in phyloge-
netic analysis.
To perform the phylogenetic analysis, assembled genome sequence was subjected to BLAST (Megablast algorithm) on NCBI
Non Redundant database. All hits obtained were of DENV-3 genome only. Fasta format of the genome sequences of the top
100 hits were downloaded. These sequences along with the obtained assembled genome sequence were then subjected to local
pair-wise Multiple Sequence Alignment (MSA) using MAFFT v7.221. Phylogenetic analysis and distance calculation were per-
formed using the MEGA v.6 software (Tamura et al., 2013) with the Neighbour-Joining method of the Maximum Composite Like-
lihood model, uniform rates among sites with 1000 bootstrap replicates.
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